Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for Excessive Sleepiness in Narcolepsy or OSAHS
NCT00228566Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of armodafinil in narcolepsy, obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Cephalon, Inc.. Started Oct 2005; status: completed.
02
Drugs
armodafinil
03
Conditions
narcolepsyobstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on NCT00228566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228566.